{
    "2018-06-19": [
        [
            {
                "time": "",
                "original_text": "华兰生物年报推10派3元 股权登记6月26日",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "年报",
                        "分红",
                        "股权登记"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "血液制品有望持续高增长！细看三大类产品市场扩容潜力",
                "features": {
                    "keywords": [
                        "血液制品",
                        "高增长",
                        "市场扩容"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中长期向上趋势不变 医药生物存“升”机",
                "features": {
                    "keywords": [
                        "中长期趋势",
                        "医药生物",
                        "上升机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【数据揭秘】融资客最看好个股一览",
                "features": {
                    "keywords": [
                        "融资",
                        "个股",
                        "数据揭秘"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "机构集中推荐119只个股 医药生物等三行业存“升”机",
                "features": {
                    "keywords": [
                        "机构推荐",
                        "医药生物",
                        "上升机会"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "首个四价流感疫苗获批 华兰生物疫苗业务有望扭亏",
                "features": {
                    "keywords": [
                        "四价流感疫苗",
                        "华兰生物",
                        "疫苗业务",
                        "扭亏"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:弱市下建议紧握确定性龙头,以时间换空间",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "确定性龙头",
                        "弱市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:pd-1单抗药物实现国内首上市",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "pd-1单抗",
                        "国内首上市"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}